Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Could thyroid dysfunction influence outcome in sunitinib-treated metastatic ... - UroToday |
![]() |
![]() |
UroToday Sunitinib is a standard of care for metastatic renal cell carcinoma (mRCC). Hypothyroidism is frequently observed under sunitinib therapy. This study was conducted to prospectively determine the correlation between thyroid function and progression-free |